- Home
- TBI vs INMB Comparison
TBI vs INMB Comparison
Compare TBI & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBI
- INMB
- Stock Information
- Founded
- TBI 1985
- INMB 2015
- Country
- TBI United States
- INMB United States
- Employees
- TBI N/A
- INMB N/A
- Industry
- TBI Professional Services
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- TBI Consumer Discretionary
- INMB Health Care
- Exchange
- TBI Nasdaq
- INMB Nasdaq
- Market Cap
- TBI 169.0M
- INMB 176.5M
- IPO Year
- TBI 1996
- INMB 2019
- Fundamental
- Price
- TBI $5.80
- INMB $7.18
- Analyst Decision
- TBI Buy
- INMB Strong Buy
- Analyst Count
- TBI 1
- INMB 3
- Target Price
- TBI $10.00
- INMB $24.33
- AVG Volume (30 Days)
- TBI 525.7K
- INMB 274.4K
- Earning Date
- TBI 05-05-2025
- INMB 05-08-2025
- Dividend Yield
- TBI N/A
- INMB N/A
- EPS Growth
- TBI N/A
- INMB N/A
- EPS
- TBI N/A
- INMB N/A
- Revenue
- TBI $1,534,794,000.00
- INMB $50,000.00
- Revenue This Year
- TBI $0.80
- INMB N/A
- Revenue Next Year
- TBI $6.90
- INMB $43,178.43
- P/E Ratio
- TBI N/A
- INMB N/A
- Revenue Growth
- TBI N/A
- INMB N/A
- 52 Week Low
- TBI $3.45
- INMB $4.32
- 52 Week High
- TBI $12.29
- INMB $10.50
- Technical
- Relative Strength Index (RSI)
- TBI 61.64
- INMB 48.52
- Support Level
- TBI $5.82
- INMB $7.15
- Resistance Level
- TBI $6.28
- INMB $8.06
- Average True Range (ATR)
- TBI 0.36
- INMB 0.45
- MACD
- TBI 0.07
- INMB -0.01
- Stochastic Oscillator
- TBI 70.33
- INMB 27.62
About TBI TrueBlue Inc.
TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.